1. Home
  2. MAMA vs VNDA Comparison

MAMA vs VNDA Comparison

Compare MAMA & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mama's Creations Inc.

MAMA

Mama's Creations Inc.

HOLD

Current Price

$15.22

Market Cap

598.8M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$6.26

Market Cap

387.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MAMA
VNDA
Founded
2010
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
598.8M
387.9M
IPO Year
2011
2005

Fundamental Metrics

Financial Performance
Metric
MAMA
VNDA
Price
$15.22
$6.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$19.00
$14.90
AVG Volume (30 Days)
349.4K
1.1M
Earning Date
04-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
44.44
N/A
EPS
0.13
N/A
Revenue
$95,420,129.00
$216,105,000.00
Revenue This Year
$31.09
$21.35
Revenue Next Year
$16.12
$37.40
P/E Ratio
$112.69
N/A
Revenue Growth
95.54
8.72
52 Week Low
$7.75
$4.14
52 Week High
$17.85
$9.91

Technical Indicators

Market Signals
Indicator
MAMA
VNDA
Relative Strength Index (RSI) 58.19 43.37
Support Level $14.43 $5.85
Resistance Level $15.68 $6.73
Average True Range (ATR) 0.65 0.23
MACD 0.07 0.02
Stochastic Oscillator 77.46 35.10

Price Performance

Historical Comparison
MAMA
VNDA

About MAMA Mama's Creations Inc.

Mama's Creations Inc manufactures and markets fresh deli-prepared foods distributed through grocery, mass, club, and convenience stores across the United States. Its product portfolio includes refrigerated prepared foods such as meatballs, meatloaf, sausage products, and pasta and rice entrees. The products are principally sold to supermarkets, club chains, mass-market retailers, and food distributors. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: